Soluventis Nanotherapeutics logo — Pioneering groundbreaking oligonucleotide therapeutics for e...

Soluventis Nanotherapeutics

Pioneering groundbreaking oligonucleotide therapeutics for effective cancer treatment with advanced systemic delivery technology.

Founded 2009 1 employees Seed Biotechnology, Health and Wellness

General Information

Company Name Soluventis Nanotherapeutics
Founded Year 2009
Founders / Decision Makers
Team member
Employees 1
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Soluventis Nanotherapeutics. To contact Soluventis Nanotherapeutics, visit soluventis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Soluventis Nanotherapeutics compare?

A PDF of Soluventis Nanotherapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Soluventis Nanotherapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Soluventis Nanotherapeutics

Soluventis Nanotherapeutics is a US-German biotechnology company that has been pioneering groundbreaking oligonucleotide therapeutics for effective cancer treatment since its establishment in 2009. The company's primary focus is on oncology, and it is based in San Diego and Bochum. Soluventis specializes in creating innovative oligonucleotide therapeutics, utilizing their proprietary platform technology to ensure effective systemic delivery of compounds with significant activity across almost all organs, including cancerous tumors and metastases. The company's last investment was a Seed Round led by Mey Capital Matrix on 01 February 2011. Soluventis Nanotherapeutics operates in the Biotechnology and Health and Wellness industries, showcasing its potential to make a significant impact in the field of cancer treatment with its advanced systemic delivery technology.

Business keywords: oligonucleotide therapeutics, systemic delivery, cancer treatment, oncology, metastases, drug development, platform technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
Mey Capital Matrix
01 Feb 2011

Soluventis Nanotherapeutics Alternatives & Competitors

View All Alternatives
Soluventis Nanotherapeutics vs
Gensun Biopharma
Gensun Biopharma United States

We are dedicated to the discovery and development of innovative biological therapeutics for the trea...

7 employees
Biopharma, Biotechnology
Soluventis Nanotherapeutics vs

A Quantum Leap Forward in the Fight Against Cancer

Non Equity Assistance
16 employees
Biotechnology, Health and Wellness
Soluventis Nanotherapeutics vs
NeoPhore Ltd
NeoPhore Ltd United Kingdom

Discovering drugs that create neoantigens

Series B
18 employees
Biotechnology, Health and Wellness

FAQ About Soluventis Nanotherapeutics

Pioneering groundbreaking oligonucleotide therapeutics for effective cancer treatment with advanced systemic delivery technology.
Soluventis Nanotherapeutics was founded in 2009.
Soluventis Nanotherapeutics operates in Biotechnology and Health and Wellness. Its work centres on oligonucleotide therapeutics, systemic delivery, cancer treatment and oncology.
Soluventis Nanotherapeutics has approximately 1 employees.
Soluventis Nanotherapeutics has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Soluventis Nanotherapeutics include Gensun Biopharma, PanTher Therapeutics, NeoPhore Ltd, Quentis Therapeutics, ImCheck Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Soluventis Nanotherapeutics and Gensun Biopharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Soluventis Nanotherapeutics, https://bouncewatch.com/company/soluventis, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes